Can aerobic exercise protect against dementia? by Graff-Radford, Neill R
Introduction
In 2005, in the US, 36 million persons were over 65. 
Strong evidence indicates that memory and other 
cognitive tasks start declining at age 50 [1]. Furthermore, 
in the US, the prevalence of dementia ranges from 5% to 
10% [2,3] and that of mild cognitive impairment (MCI) 
ranges from 12% to 18% [4,5]. Cognitive decline is 
common in persons over 70 and has an important impact 
on quality of life. To improve the quality of life for older 
persons, it is imperative that we begin to understand 
which factors contribute to cognitive decline and brain 
atrophy. Furthermore, we need to determine which bio-
markers or neurological measures can be used to predict 
these conditions and what therapeutic inter  ventions can 
improve an individual’s brain health. Recently, moderate 
exercise and improved ﬁ  tness were shown to enhance 
cognition in cognitively normal older persons as well as 
in individuals who complain of memory diﬃ   culty  [6]. 
Additionally, ﬁ   tness correlates with brain volume in 
persons who are cognitively normal [7] and in those with 
Alzheimer’s disease (AD) [8]. In this paper, we shall 
discuss the following:
1. Th  e causes of cognitive decline in older persons and 
why exercise could be a broad-spectrum intervention 
for dementia.
2.   After this, we shall present epidemiological evidence 
that exercise may slow cognitive decline and decrease 
the chance of dementia.
3.  Th  en we shall discuss the randomized control trials 
that provide evidence that exercise has a positive eﬀ  ect 
on improving cognition.
4.  Following that, the paper will report the animal studies 
showing that exercise may be protective of the brain.
5.    Lastly, we shall discuss biomarkers, starting with 
imaging and moving onto telomeres, plasma measures, 
cerebrospinal ﬂ  uid (CSF) measures, and inﬂ  ammatory 
biomarkers.
1A. Causes of cognitive decline in older persons
Th  e three most common forms of dementia are AD, 
Lewy body disease (LBD), and vascular dementia (VaD) 
[9] and all contribute to cognitive decline and brain 
atrophy. Noting that mixed dementia (having overlapping 
contributions) is common, Dickson and colleagues [9] 
reported that, in the Florida Brain Bank, the most 
frequent pathologies contributing to dementia were AD 
(77%), followed by LBD (26%), and then VaD (18%). In 
support of this ﬁ  nding is a paper by the Rush group [10], 
which reported the pathological and cognitive ﬁ  ndings 
from two prospective community-based studies; in 652 
patients who had come to autopsy, the three pathologies 
above were signiﬁ   cantly associated with the cognitive 
measures.
Compelling studies show that cognitively normal older 
persons frequently have AD pathology. In 2,661 autopsy 
cases, Braak and Braak [11] reported that 27% of persons 
over 70 and 39% over 75 have signiﬁ  cant amyloid (stages 
B and C) and tau (greater than stage III) pathology. In 
support of this observation, amyloid Aβ imaging in 
cognitively normal older individuals revealed that 21% 
[12] to 30% [13] had positive scans. A recent study [14] 
indicates that the prevalence curve by age for positive 
Pittsburgh compound-B (PIB) scans in cogni  tively 
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measures from Braak and Braak’s [11] autopsy study in 
nondemented persons. Very interestingly, this curve 
parallels the AD prevalence curve but is 15 years earlier 
than the AD curve. Th  is 15-year window may be the 
opportunity to prevent AD with interventions such as 
exercise. We also point out that, in the Rush community-
based study [10], AD pathology, vascular disease, and 
Lewy body pathology are common in cognitively normal 
persons.
1B. Could exercise be a broad-spectrum intervention?
It has long been known that exercise may have many 
health beneﬁ  ts. Studies suggest that it decreases mortality 
[15], improves cardiovascular function [16], enhances 
cognitive functioning [17,18], decreases coronary heart 
disease [19], decreases fall risk in older persons [20], and 
improves depression [21]. Barnes and colleagues [22], in 
a review, summarized the eﬀ  ects of exercise on obesity, 
vascular disease, hypertension, diabetes, and inﬂ  amma-
tion and how all of these factors may be protective of the 
brain. It is possible that exercise helps protect against the 
three most common dementia pathologies. In an AD 
transgenic mouse model, Lazarov and colleagues [23] 
showed that environmental enrichment, including an 
exer  cise wheel, decreased Aβ brain deposits. In the 
rodent Parkinson disease (PD) models, exercise was 
protective against motor but not cognitive tasks [24] and 
improved the density of blood vessels and mRNA 
vascular endothelial growth factor (VEGF) activity in the 
nigra [25]. Clinically, Crizzle and colleagues [26] re-
viewed exercise and PD and concluded that ‘patients with 
PD improve their physical performance and activities of 
daily living through exercise’. But that review did not 
address cognitive improvement. Lastly, there is good 
evidence that exercise may be protective against stroke 
and VaD [27,28].
2. Epidemiological studies on exercise show 
protective eff  ects on cognition
2A. Exercise may preserve cognition and slow cognitive 
decline
Yaﬀ  e and colleagues [29] followed 5,925 women (more 
than 65 years old) for 6 to 8 years with baseline self-
report exercise measures. Women with a greater physical 
activity level at baseline experienced less cognitive decline 
during the 6 to 8 years of follow-up: cognitive decline 
occurred in 17%, 18%, 22%, and 24% of those in the 
highest, third, second, and lowest quartiles of blocks 
walked per week, respectively (P <0.001 for trend).
Weuve and colleagues [30] used baseline energy expen-
diture measures from a survey of 18,766 nurses. Th  e 
authors found, on a global cognitive score, that women in 
the second through ﬁ  fth quintiles of energy expenditure 
scored an average of, respectively, 0.06, 0.06, 0.09, and 
0.10 standard units higher than women in the lowest 
quintile (P for trend <0.001). Th   e authors also observed 
less cognitive decline among women who were more 
active, especially those in the two highest quintiles of 
energy expenditure.
A recent report by Middleton and colleagues [31] noted 
that women who gave a history of being physically active 
at any time in life, especially as teenagers, had a lower 
chance of cognitive decline in late life. Nine thousand 
three hundred forty-four women (65 years old or older, 
mean 71.6 years) self-reported teenage, age 30, age 50, 
and late-life physical activity. Women who reported being 
physically active had a lower prevalence of cognitive 
impairment in late life than women who were inactive at 
each stage.
2B. Exercise is associated with decreased incident 
dementia
Abbott and colleagues [32], in a study of 2,257 men, 
reported that men who walked the least (<0.25 miles/day) 
experienced a 1.8-fold excess risk of dementia in com-
pari  son with those who walked more than 2 miles/day 
(17.8 versus 10.3/1,000 person-years; relative hazard 1.77, 
95% conﬁ  dence interval [CI] 1.04 to 3.01).
Larson and colleagues [7] followed 1,740 persons (older 
than 65 years) for an average of 6.2 years with respect to 
incident dementia. Th   e incidence rate was 13.0 per 1,000 
person-years for participants who exercised three or 
more times per week in comparison with 19.7 per 1,000 
person-years for those who exercised less. Th   e age- and 
sex-adjusted hazard ratio of dementia was 0.62 (95% CI 
0.44 to 0.86; P = 0.004).
In a population-based study [33] of physical exercise 
frequency between 198 subjects with MCI and 1,126 
cognitively normal subjects, moderate exercise was less 
common in the MCI group. Th  e odds ratios for any 
frequency of moderate exercise were 0.61 (95% CI 0.43 to 
0.88; P = 0.008) for midlife (age of 50 to 65 years) and 0.68 
(95% CI 0.49 to 0.93; P = 0.02) for late life.
A recent meta-analysis reported by Hamer and Chida 
[34] included 16 studies with exercise measures, includ-
ing 163,797 controls at baseline and 3,219 incident cases 
of dementia or PD. Th  e authors found that the relative 
risks in the highest physical activity category compared 
with the lowest were 0.72 (95% CI 0.60 to 0.86; P <0.001) 
for dementia, 0.55 (95% CI 0.36 to 0.84; P = 0.006) for 
AD, and 0.82 (95% CI 0.57 to 1.18; P = 0.28) for PD. 
While this provides support that exercise may be 
protective against dementia, there is less support of its 
being protective against dementia in PD.
Aarsland and colleagues [28] completed a meta-analy-
sis evaluating whether exercise might protect against 
VaD and found ﬁ   ve studies that met criteria for 
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subjects and 374 individuals with VaD. Th  e  meta-analysis 
demon  strated a signiﬁ  cant association between physical 
exercise and a reduced risk of developing VaD (odds ratio 
0.62, 95% CI 0.42 to 0.92).
3. Randomized control trials
A recent Cochrane systematic review of 11 studies of 
aerobic exercise programs for healthy older persons [35] 
indicated that 8 of the studies reported cognitive im-
prove  ment associated with ﬁ  tness improvement. Accord-
ing to the review, the largest and most consistent cogni-
tive eﬀ  ects in meta-analyses were observed on measures 
of cognitive speed and attention. Changes across other 
cognitive domains (for example, memory, language, and 
visuospatial) were also present but varied across 
individual studies.
In a single-blind study [6] from Australia, moderate 
exercise (50 minutes three times per week for 6 months) 
was shown to enhance cognition in cognitively normal 
older persons as well as in individuals who complained of 
memory diﬃ   culty. Th   is was a randomized controlled trial 
of a 24-week physical activity intervention with a total of 
170 participants, and 138 participants completed the 
18-month assessment. Th  e main outcome measure was 
the Alzheimer’s Disease Assessment Scale-Cognitive 
Sub  scale (ADAS-Cog) at 18 months. Th  e investigators 
found that, in an intent-to-treat analysis, participants in 
the intervention group improved 0.26 points (95% CI 
−0.89 to 0.54) and those in the usual care group 
deteriorated 1.04 points (95% CI 0.32 to 1.82) on the 
ADAS-Cog at the end of the intervention. Th   is showed a 
modest improvement at 18 months after 6  months of 
exercise intervention.
In a randomized control trial by Erikson and colleagues 
[36], 120 cognitively normal sedentary adults from 55 to 
80 years old were randomly assigned to aerobic exercise 
(building up to walking 40 minutes four times per week) 
or toning and stretching. Th  e authors found that the 
hippocampi in the aerobics group increased by 1% to 2% 
per year whereas in the stretching group the hippocampi 
decreased by 1.4% per year. Th   e authors measured ﬁ  tness 
with peak oxygen consumption, and the better the ﬁ  tness, 
the larger the hippocampi on the magnetic resonance 
imaging (MRI) measures. Greater elevations in serum 
brain-derived neurotrophic factor (BDNF) correlated 
with greater hippocampal volume gain. Th   ose with better 
ﬁ  tness at baseline and at 12 months scored better on 
memory tests. Th  is study shows the usefulness of bio-
markers in understanding the eﬀ  ects of aerobic exercise.
A pilot MCI exercise study [37] of 16 males and 17 
females randomly assigned to aerobic exercise or stretch-
ing for 6 months reported that aerobic exercise improved 
executive function in both men and women. Exercise also 
increased glucose disposal and reduced fasting plasma 
insulin, cortisol, and BDNF in women and increased 
plasma insulin-like growth factor I in men.
4. Animal studies
4A. What other factors that may improve brain health does 
exercise impact?
A review by Cotman and colleagues [38] indicates that 
exercise aﬀ  ects growth factors such as BDNF, increases 
synaptic plasticity, increases neurogenesis, and reduces 
peripheral factors such as diabetes, hypertension, and 
cardiovascular disease. Th  e authors suggest a common 
mechanism of exercise on both the peripheral and central 
eﬀ   ects in that decreasing inﬂ  ammation  increases 
successful brain function.
4B. Mouse models of Alzheimer’s disease and exercise
van Praag and colleagues [39] showed that voluntary 
exercise alone increased dentate gyrus neurogenesis. Th  is 
is separate from environmental enrichment, which also 
increases neurogenesis.
Ambree and colleagues [40] showed the interaction 
between an active lifestyle and AD pathology in female 
TgCRND8 mice carrying human APPswe+ind gene. 
Th  ese mice were housed in enriched housing in their 
cages. Four months in this environment resulted in a 
signiﬁ   cant reduction of beta-amyloid plaques and 
amyloid angiopathy [40]. Costa and colleagues [41], in a 
similar study, showed that the environmental enrichment 
in transgenic mice improved the cognitive functioning 
and decreased the brain Aβ pathology. Adlard and 
colleagues [42] used the TgCRND8 transgenic mouse 
model and showed that 5 months of voluntary exercise 
resulted in a decrease in extracellular Aβ plaques in the 
frontal cortex (38%; P = 0.018), the cortex at the level of 
the hippocampus (53%; P = 0.0003), and the hippocampus 
(40%; P = 0.06). Long-term exercise also enhanced the 
rate of learning of TgCRND8 animals in the Morris water 
maze, with signiﬁ  cant  (P <0.02) reductions in escape 
latencies over the ﬁ  rst 3 (of 6) trial days.
Lazarov and colleagues [23] reported that exposure of 
transgenic mice to an ‘enriched environment’, including 
an exercise wheel, resulted in reductions in cerebral Aβ 
levels and amyloid deposits in comparison with animals 
raised under ‘standard housing’ conditions. Th  e  authors 
found that the enzymatic activity of an Aβ-degrading 
endopeptidase, neprilysin, is elevated in the brains of 
‘enriched’ mice and inversely correlated with Aβ burden. 
Lastly, in a recent paper, Hu and colleagues [43] reported 
that, in mice with the familial AD-linked mutant APPswe/
PS1DeltaE9, environmental enrichment en  hanced neuro-
genesis and was accompanied by a signiﬁ  cant reduction 
in levels of hyperphosphorylated tau and oligomeric Aβ. 
Th  e authors concluded that ‘environmental modulation 
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brain and that induction of brain plasticity may represent 
therapeutic and preventive avenues in AD’ [43].
5. Biomarkers
5A. Structural brain changes
Cognitive decline is associated with brain atrophy in 
cognitively normal persons
Jack and colleagues [44] showed that in cognitively 
normal persons the change of brain atrophy over time is 
associated with a change in cognitive scores. Th  e  authors 
looked at change in hippocampal, whole brain, and 
ventricle volumes in relationship to the Mini-Mental 
Status Examination [45], Dementia Rating Scale [46], Rey 
Auditory Verbal Learning Test [47] and the logical 
memory subtest of the Weschler Memory Scale [48] and, 
using the Spearman rank correlation, found a signiﬁ  cant 
correlation between change in all volume measures and 
change in all test scores.
Associations between cardiovascular fi  tness and brain 
volume
Exercise improves certain cognitive tasks but are these 
related to structural brain measures? One of the ﬁ  rst 
studies showing that exercise inﬂ  uences the structure of 
the brain was by Colcombe and colleagues [49], who 
reported on 59 older persons, half of whom underwent 
aerobic training and half of whom participated in toning 
and stretching. Th  e authors also measured maximal 
oxygen uptake. Th   ey found on MRI that gray and white 
matter brain areas increased in the aerobic but not the 
control group and this was related to a function of ﬁ  tness 
training.
Burns and colleagues [8] showed that increased cardio-
respiratory ﬁ  tness (VO2
peak) is associated with increased 
brain volume, suggesting that increased ﬁ  tness may be 
associated with decreased brain atrophy in AD.
In a study involving both mice and humans, Pereira and 
colleagues [50] showed that, as exercise improves ﬁ  tness, 
there may be neurogenesis in the dentate gyrus, which in 
turn could improve learning. In mice, exercise-induced 
increases in dentate gyrus cerebral blood volume (CBV) 
were found to correlate with postmortem measurements 
of neurogenesis. In humans, exercise was found to have a 
primary eﬀ  ect on dentate gyrus CBV and this selectively 
correlated with cardiopulmonary (ﬁ  tness) and cognitive 
(learning) function. From this, the authors extrapolated 
that exercise may induce neurogenesis in the dentate 
gyrus, which in turn may improve learning.
Erickson and colleagues [51] completed a cross-
sectional study evaluating hippocampal volume, aerobic 
ﬁ  tness, and spatial memory in 165 nondemented older 
adults and found that (a) higher ﬁ  tness levels were asso-
ciated with larger hippocampi after age, sex, and years of 
education were controlled for; (b) larger hippocampi and 
higher ﬁ   tness levels correlated with better spatial 
memory; and (c) hippocampal volume partially mediated 
the relationship between higher ﬁ   tness levels and 
enhanced spatial memory, suggesting that exercise may 
be protective of hippocampus, which in turn preserves 
cognition. Th   e authors point out that they used 
meditational analysis and that a causal eﬀ  ect should be 
interpreted cautiously because unmeasured factors such 
as diet could co-vary with hippocampal volume and 
account for the mediation. Th  ey suggest that future 
studies use longitudinal designs, clinical populations, and 
other measuring techniques to validate the ﬁ  nding.
5B. Telomeres
Telomere length is a marker of cellular aging and has 
been associated with dementia [52]. A report [53] 
involving 2,401 twins found that leukocyte telomere 
length was 200 nucleotides longer in those most active 
compared with those least active. Twins discordant for 
exercise amount showed that twins doing more exercise 
had longer telomeres. Another study [54] showed that 
leukocyte telomere length was longer in duration trained 
individuals, with VO2
peak explaining 60% of the variance. 
Th   e Health ABC study [55] reported that telomere length 
may serve as a biomarker of cognitive aging. Th  e  investi-
gators noted that baseline telomere length was associated 
with digit symbol scores (36.4, 34.9, and 34.4 points for 
long, medium, and short, respectively; P  <0.01). Th  e 
7-year Modiﬁ  ed Mini-Mental Status Exami  nation change 
scores were lower among those with longer telomere 
length (−1.7 versus −2.5 and −2.9 points; P = 0.01). Th  e 
investigators concluded that telomere length may serve 
as a biomarker for cognitive aging. Th   ere is a clear need 
for a prospective controlled study evaluating the eﬀ  ect of 
exercise on telomere length.
5C. Plasma Aβ
Exercise is known to decrease inﬂ  ammatory markers [56] 
and improve insulin sensitivity [57,58]. Th  is  is  important 
because Cotman and colleagues [38] have postulated that 
the common mechanism whereby exercise improves 
brain health is through decreasing inﬂ  ammation.  We 
hypothesize that both Aβ40 and Aβ42 will decrease with 
exercise. Interestingly, a nonsigniﬁ  cant trend toward a 
decline in plasma Aβ42 was observed in a small, MCI 
exercise study [37].
5D. Cerebrospinal fl  uid Aβ42 and Pittsburgh 
compound-B scanning
Liang and colleagues [59] reported a study of 69 older 
adults who had PIB and CSF measures of Aβ42 and tau. 
Th  e authors administered an exercise questionnaire 
estimating the amount of exercise performed in the 
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PIB and tau had signiﬁ  cantly lower exercise scores. Th  e 
PIB association remained signiﬁ  cant after adjustment for 
covariates. Th  ose doing 7.5 metabolic equivalent task 
(MET) hours/week (which is equal to 30 minutes ﬁ  ve 
times per week) had signiﬁ  cantly lower PIB (P = 0.006) 
and higher CSF Aβ42 (P = 0.001) after covariates were 
controlled for.
A recent study [14] indicates that the prevalence curve 
by age for positive PIB scans in cognitively normal 
persons overlies the prevalence of amyloid plaque 
measures from Braak and Braak’s [11] autopsy study in 
nondemented persons. Very interestingly, this curve 
parallels the AD prevalence by age but is 15 years earlier 
at each age. Th   is 15-year window may be the opportunity 
to prevent AD with interventions such as exercise.
5E. Infl  ammatory biomarkers
Whereas cross-sectional studies show that inﬂ  ammatory 
biomarkers such as C-reactive protein are lower in 
persons who exercise [60,61], a randomized control trial 
did not show that exercise decreases C-reactive protein 
[62].
Conclusions
Th   ere is increasing evidence from basic research, 
including transgenic mouse experiments, epidemiology, 
biomarkers, and a limited number of prospective studies, 
that aerobic exercise may be protective of brain health by 
changing chemical factors in the brain and warding oﬀ   
diseases and other factors related to brain disease, such 
as diabetes, hypertension, and inﬂ  ammation. Th   e time is 
ripe to do prospective studies to validate this assertion.
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